Use of PERCIST for prediction of progression-free and overall survival after radioembolization for liver metastases from pancreatic cancer

M Michl, S Lehner, PM Paprottka, H Ilhan… - Journal of Nuclear …, 2016 - Soc Nuclear Med
We evaluated the prognostic accuracy of established PET response criteria in patients with
liver metastases from pancreatic cancer after treatment with 90Y microspheres. Methods …

Validation of several SUV-based parameters derived from 18F-FDG PET for prediction of survival after SIRT of hepatic metastases from colorectal cancer

WP Fendler, DBP Tiega, H Ilhan… - Journal of Nuclear …, 2013 - Soc Nuclear Med
90Y radioembolization (selective internal radiation therapy [SIRT]) is a valuable therapeutic
option for unresectable hepatic metastases arising from primary colorectal cancer. The …

Early metabolic response assessment of breast cancer liver metastases: 4-week posttreatment FDG PET predicts survival after 90Y microsphere radioembolization

A Sabet, M Ries, Y Al-Khalaf, C Meyer… - Nuklearmedizin …, 2019 - thieme-connect.com
Aim To evaluate the feasibility of early metabolic response assessment with 18 F-FDG
PET/CT in patients with breast cancer liver metastases 4 weeks after radioembolization with …

18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer

AR Haug, BPT Donfack, C Trumm… - Journal of Nuclear …, 2012 - Soc Nuclear Med
90Y radioembolization (selective internal radiation therapy [SIRT]) has emerged as a
valuable therapeutic option in unresectable, chemotherapy-refractory hepatic metastases …

The role of routine clinical pretreatment 18F-FDG PET/CT in predicting outcome of colorectal liver metastasis

HH Tam, GJ Cook, I Chau, B Drake… - Clinical nuclear …, 2015 - journals.lww.com
Objective The aim of this study was to determine the value of SUV-based metabolic
parameters derived from pretreatment 18 F-FDG PET/CT of colorectal liver metastases in …

FDG PET for monitoring response to local and locoregional therapy in HCC and liver metastases

R Dierckx, A Maes, M Peeters… - The Quarterly Journal …, 2009 - search.proquest.com
Local ablative therapies and loco-regional therapies are being increasingly used for the
purpose of providing local control of primary liver tumors and liver metastases while sparing …

Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after 90Y radioembolization of colorectal liver metastases: a …

W Shady, S Kishore, S Gavane, RK Do… - European journal of …, 2016 - Elsevier
Purpose To compare the performance of 4 metrics of metabolic response on FDG-PET/CT
against RECIST 1.0 for determining response and predicting overall survival (OS) following …

Early post-treatment FDG PET predicts survival after 90Y microsphere radioembolization in liver-dominant metastatic colorectal cancer

A Sabet, C Meyer, A Aouf, A Sabet, S Ghamari… - European journal of …, 2015 - Springer
Purpose The aim of this study was to evaluate the predictive value of early metabolic
response 4 weeks post-treatment using 18 F-fluorodeoxyglucose (FDG) positron emission …

18F-FDG PET/CT is an immediate imaging biomarker of treatment success after liver metastasis ablation

F Cornelis, V Storchios, E Violari… - Journal of Nuclear …, 2016 - Soc Nuclear Med
The rationale of this study was to examine whether 18F-FDG PET/CT and contrast-
enhanced CT performed immediately after percutaneous ablation of liver metastases are …

Predictive value of maximum standardized uptake value (SUVmax) on 18F-FDG PET/CT in patients with locally advanced or metastatic pancreatic cancer

SY Moon, KR Joo, YR So, JU Lim, JM Cha… - Clinical Nuclear …, 2013 - journals.lww.com
Purpose We investigated the prognostic role of 18 F-FDG PET/CT in the prediction of
progression-free survival (PFS) and chemotherapeutic response in patients with locally …